Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Lesson of the month 2: Toxic shock syndrome

Tamer Shalaby, Samantha Anandappa, Nicholas John Pocock, Alexander Keough and Angus Turner
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.14-3-316
Clin Med June 2014
Tamer Shalaby
AHealth Education Kent Surrey Sussex and Maidstone Hospital, Maidstone, UK
Roles: ST5 in acute medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: t.shalaby@nhs.net
Samantha Anandappa
BMaidstone Hospital, Maidstone, UK
Roles: CMT1
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas John Pocock
CMaidstone Hospital, Maidstone, UK
Roles: clinical fellow in anaesthetics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Keough
DMaidstone Hospital, Maidstone, UK
Roles: consultant acute physician and rheumatologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angus Turner
EMaidstone Hospital, Maidstone, UK
Roles: consultant anaesthetist and intensive care
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

Toxic shock syndrome (TSS) represents a fascinating example of immune activation caused by infection resulting in a dramatic and challenging clinical syndrome. TSS is commonly associated with tampon use and still causes significant morbidity and mortality in young healthy women. A misconception is that TSS presents with a skin rash and only occurs in women and children; however, it can occur in males and can present without skin changes. TSS presents initially as a febrile illness and within a few hours can progress to severe hypotension and multiple organ failure (MOF). Staphylococcus aureus and group A beta haemolytic streptococcus (GABHS) can secrete toxins from a small or hidden focus of infection and hence blood culture and sensitivity (C+S) tests can be negative, thereby making diagnosing this condition challenging. Clindamycin is superior to penicillin in the treatment of this condition and significantly decreases the mortality rate in TSS. However, there is also an important role for intravenous immunoglobulins (IVIG). Early intensive care unit (ICU) as well as surgical team involvement (in selected cases) is required to avoid mortality which may approach 70%.

KEYWORDS 
  • Toxic shock syndrome (TSS)
  • group A beta haemolytic streptococcus (GABHS)
  • Staphylococcus aureus
  • necrotising fasciitis
  • multiple organ failure
  • intravenous immunoglobulins

Presentation

A 45-year-old female patient presented to the accident and emergency department (A&E) having been generally unwell for the past 12 hours. She had begun to develop rigors. Her past medical history was of birdshot chorioretinopathy, an autoimmune disease causing posterior uveitis, for which she was taking prednisolone and mycophenolate mofetil. She denied any preceding flu-like illness or respiratory, urinary or gastrointestinal symptoms. She had neither headaches nor neck stiffness. She worked as a teaching assistant and was a mother to two children who were well. She did not consume alcohol, had never smoked and had no recent travel history.

On examination she had a temperature of 39.7°C and tachycardia at 110 beats per minute. However, her blood pressure (BP), oxygen saturations and respiratory rate were within normal limits and she was fully alert and orientated. Cardiorespiratory and abdominal examination was normal. There were no signs of skin rash, joint swelling or stigmata of infective endocarditis. An oral examination revealed good oral hygiene, but mild pharyngitis was noted. Electrocardiography (ECG) showed sinus tachycardia and chest X-ray was unremarkable. A urine dipstick test only revealed a trace of blood and was negative for nitrites and leucocytes. Bloods on admission showed venous lactate of 1 mmol/l (blood results are shown in Table 1). Initially this gave an impression of sepsis with unknown origin (in view of fever on a background of an immunosuppressed status). The treatment plan included intravenous (IV) crystalloid fluids, Tazocin (broad spectrum antibiotic) after blood cultures were taken, doubling the dose of prednisolone and omitting the mycophenolate mofetil, pending the results of the septic screen.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Blood results in the first 24 hours.

However, 2 hours later it was noted the patient appeared to be drowsy, but responsive and obeying commands. Another hour later the patient was given a computed tomography (CT) scan of the head following further concerns about her progressive drowsiness. This was reported as normal and a lumbar puncture was planned to rule out meningoencephalitis. Following the CT scan, she became profoundly hypotensive with a systolic BP of 60–70 mmHg. Given the amount of fluid resuscitation needed, a catheter was inserted by nursing staff who reported that there was a tampon present with some green discharge. This was removed and sent for culture and sensitivity (C+S) testing. The patient reported that the tampon had been inserted less than 12 hours prior to admission. A diagnosis of toxic shock syndrome was made and the patient was transferred to the intensive care unit (ICU).

Following advice from the microbiology department the patient was started on clindamycin and meropenem treatment on arrival at ICU, and Tazocin was discontinued. Noradrenaline was commenced; however, it soon became clear that the patient had developed vasoplegia secondary to severe sepsis. Adrenaline and vasopressin were subsequently commenced with good effect. Intravenous immunoglobulin (IVIG) was also started. Despite vasopressors and aggressive fluid resuscitation the patient remained oliguric and became progressively more acidotic. Continuous veno-venous haemofiltration (CVVHF) was initiated. After 3 days on intensive care she was weaned off the CVVHF and vasopressor support, and transferred to ward care. Four days later she was discharged home from the ward, with advice from the gynaecologist to not use tampons again. A high vaginal swab subsequently grew Staphylococcus aureus, while two sets of blood C+S tests were negative.

Discussion

Toxic shock syndrome (TSS) is an acute systemic illness associated with infection by strains of S aureus which produce toxic shock syndrome toxins (TSST-1) or streptococcus pyogenes M types I and III – mainly group A beta haemolytic streptococcus (GABHS)-producing streptococcal pyogenic exotoxin A (SPEA). TSST-1 and SPEA are ‘super-antigens’ that interact with antigen-presenting cells (APCs) and T Cells to induce T Cell proliferation and massive cytokine production including tumour necrosis factor (TNF)-α, TNF-β, interleukin (IL)-1, IL-2 and IL-6, causing severe shock1–2.

S aureus infection can be divided into menstrual and non-menstrual cases (ie postmenopausal women, men and children). Menstrual cases are associated with vaginal colonisation with a toxigenic strain of S aureus-producing TSST-1 followed by penetration of a sufficient concentration of TSST-1 across the epithelium, aided by abrasion from barrier contraception or tampon use. The absence of, or depression in, titres of neutralising antibody to the toxin, as in an immunosuppresed host, can enhance the severity of TSS.1–3

The focus of infection in non-menstrual cases of S aureus TSS can be pharyngitis, burns, cellulitis or even simple skin abrasion.1–3 GABHS TSS occurs more commonly in patients who are intravenous drug users, have had surgical implants and potentially in those with simple blunt trauma. It is enhanced in an immunosuppressed patient including those with diabetes, alcoholism and steroid use.4

Clinical presentation of S aureus TSS is usually an abrupt onset of fever (ie a temperature of >38.9°C), vomiting, diarrhoea and abdominal pain, macular erythroderma involving palms and soles with desquamation 1–2 weeks later, mucous membrane hyperaemia (vaginal, oesophageal and conjunctival), sore throat, myalgia, headache and photophobia.4 It is worth mentioning that our patient had not complained of gastrointestinal tract (GIT) disturbance, nor had a skin rash. Hypotension with multiple organ failure (MOF) occurs usually within 72 hours with an estimated mortality rate of 5%.5 GABHS TSS differs in that it is usually present with flu-like symptoms and febrile illness, but GIT disturbance is much less likely and rash occurs in only 10% of cases.6

Infective myositis and necrotising fasciitis occurs in 70% of patients as GABHS usually arises from a deep-seated area of the skin or after minor blunt trauma.7 Hypotension and MOF develops within 4–8 hours in 95% of patients with a mortality rate of up to 70%.6–10

Investigations

Clinical suspicion is the most important step, as there may be no clues. Common laboratory findings include abnormal liver function tests with hypoalbuminemia, acute renal failure, low platelet count and raised creatinine kinase.14

Skin, vaginal and pharyngeal swabs (according to the focus of infection) can confirm the source of infection. Blood C+S may be positive and, in cases of GABHS TSS, antistreptolysin O titre (ASOT) may be detected.14,15

Failure to treat the infection with penicillin is common. Clindamycin is superior to penicillin because of its potency in suppressing bacterial toxin synthesis as well as facilitating phagocytosis. Clindamycin also suppresses lipopolysaccharide-induced monocyte synthesis of TNF-α.16

Intravenous immunoglobulin (IVIG) therapy reduces T cell production of pro-inflammatory cytokines, and significantly increases the plasma neutralising activity against super-antigens, thereby resulting in improved survival in many TSS studies.16,17 IVIG therapy has also demonstrated an anti-TSST-1 effect and significantly improved survival in cases of S aureus TSS.18

Identification of potentially implicated foreign bodies – especially tampons, surgical drainage and irrigation or excision of infected sites such as implants or necrotizing fasciitis – is of high priority, and input from surgical teams can be essential.

Our case emphasises the importance of maintaining a high level of suspicion for TSS in patients who are at high risk of the condition (eg menstruating ladies using tampons, patients who are immunosuppressed, and patients who have trauma, burns, cellulitis, pharyngitis or implants) and who are presenting with a febrile illness and signs of shock or hypoperfusion. It is important to take a formal and accurate menstrual and sexual history in selected cases.

Fluid resuscitation and intravenous antibiotics after blood C+S is essential and early ICU involvement for possible vasopressors, haemofiltration and IVIG use is required. Surgical excision of any focus of infection may result in a significant decrease in morbidity and mortality.

Key points

  • Menstrual and sexual history including tampon or barrier use is vital

  • Toxic shock syndrome (TSS) should be suspected in immunosuppressed patients as well as in menstruating ladies using tampons who present with febrile illness with no obvious source of infection

  • Hypotension and multiple organ failure occur within hours and can be resistant to aggressive fluid and antibiotic therapy

  • Infective myositis and necrotising fasciitis can occur in 70% of group A beta haemolytic streptococcus (GABHS) TSS cases

  • Blood culture and sensitivity can be negative in TSS

  • Clindamycin is superior to penicillin in upper case and there is a role for intravenous immunoglobulins

  • © 2014 Royal College of Physicians

References

  1. ↵
    1. Brosnahan AJ,
    2. Schlievert PM
    . Gram-positive bacterial superantigen outside-in signalling causes toxic shock syndrome. FEBS J 2011;278:4649–67.doi:10.1111/j.1742-4658.2011.08151.x
    OpenUrlCrossRefPubMed
  2. ↵
    1. Matsuda Y1,
    2. Kato H,
    3. Ono E,
    4. et al.
    Diagnosis of toxic shock syndrome by two different systems; clinical criteria and monitoring of TSST-1-reactive T cells. Microbiol Immunol 2008;52:513–21.doi:10.1111/j.1348-0421.2008.00071.x
    OpenUrlCrossRefPubMed
  3. ↵
    1. Hackett SP,
    2. Stevens DL
    . Streptococcal toxic shock syndrome: synthesis of tumour necrosis factor and interleukin-1 by monocytes stimulated with pyogenic exotoxin A and streptolysin O. J Infect Dis 1992;165:879–85.doi:10.1093/infdis/165.5.879
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Dellaripa PF
    . Toxic shock syndrome. Journal of Intensive Care Medicine 2000;15:314–20.doi:10.1046/j.1525-1489.2000.00314.x
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Hajjeh RA,
    2. Reingold A,
    3. Weil A,
    4. et al.
    Toxic shock syndrome in the United States: surveillance update, 1979–1996. Emerg Infect Dis 1999;5:807–10.doi:10.3201/eid0506.990611
    OpenUrlCrossRefPubMed
  6. ↵
    1. Stevens DL,
    2. Tanner MH,
    3. Winship J,
    4. et al.
    Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989;321:1–7.doi:10.1056/NEJM198907063210101
    OpenUrlCrossRefPubMed
  7. ↵
    1. Stevens DL
    . Invasive group A streptococcus infections. Clin Infect Dis 1992;14:2–11.doi:10.1093/clinids/14.1.2
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Holm SE,
    2. Norrby A,
    3. Bergholm AM,
    4. Norgren M
    . Aspects of pathogenesis of serious group A streptococcal infections in Sweden 1988–1989. J Infect Dis 1992;166:31–37.doi:10.1093/infdis/166.1.31
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Stegmayr B,
    2. Björck S,
    3. Holm S,
    4. et al.
    Septic shock induced by group A streptococcal infections: clinical and therapeutic aspects. Scand J Infect Dis 1992;24:589–97.doi:10.3109/00365549209054644
    OpenUrlCrossRefPubMed
  10. ↵
    1. Demers B,
    2. Simor AE,
    3. Vellend H,
    4. et al.
    Severe invasive group A streptococcus infections in Ontario, Canada: 1987–1991. Clin Infect Dis 1993;16:792–800.doi:10.1093/clind/16.6.792
    OpenUrlAbstract/FREE Full Text
    1. Barnham MR,
    2. Weightman NC,
    3. Anderson AW,
    4. Tanna A
    . Streptococcal toxic shock syndrome: a description of 14 cases from North Yorkshire, UK. Clin Microbiol Infect 2002;8:174–81.doi:10.1046/j.1469-0691.2002.00396.x
    OpenUrlCrossRefPubMed
    1. Todd J,
    2. Fishaut M,
    3. Kapral F,
    4. Welch T
    . Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet 1978;2:1116–8.doi:10.1016/S0140-6736(78)92274-2
    OpenUrlCrossRefPubMed
    1. Lowy FD
    . Staphylococcus aureus infections. N Eng J Med 1998;339:520–32.doi:10.1056/NEJM199808203390806
    OpenUrlCrossRefPubMed
  11. ↵
    1. Chapnick EK,
    2. Gradon JD,
    3. Lutwick LI,
    4. et al.
    Streptococcal toxic shock syndrome due to noninvasive pharyngitis. Clin Infect Dis 1992;14:1074–7.doi:10.1093/clinids/14.5.1074
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Parsonnet J,
    2. Hansmann MA,
    3. Delaney ML,
    4. et al.
    Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J Clin Microbiol 2005;43:4628–34.doi:10.1128/JCM.43.9.4628-4634.2005
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Korman TM,
    2. Boers A,
    3. Gooding TM,
    4. et al.
    Fatal case of toxic shock-like syndrome due to group C streptococcus associated with superantigen exotoxin. J Clin Microbiol 2004;42:2866–9.doi:10.1128/JCM.42.6.2866-2869.2004
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Darenberg J,
    2. Ihendyane N,
    3. Sjölin J
    . Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003;37:333–40.doi:10.1086/376630
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Melish ME,
    2. Frogner K,
    3. Hirata S,
    4. et al.
    Use of IVIG for therapy in the rabbit model of TSS [Abstract]. Clin Res 1987;35:220.
    OpenUrl
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Lesson of the month 2: Toxic shock syndrome
Tamer Shalaby, Samantha Anandappa, Nicholas John Pocock, Alexander Keough, Angus Turner
Clinical Medicine Jun 2014, 14 (3) 316-318; DOI: 10.7861/clinmedicine.14-3-316

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Lesson of the month 2: Toxic shock syndrome
Tamer Shalaby, Samantha Anandappa, Nicholas John Pocock, Alexander Keough, Angus Turner
Clinical Medicine Jun 2014, 14 (3) 316-318; DOI: 10.7861/clinmedicine.14-3-316
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Presentation
    • Discussion
    • Investigations
    • References
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Toxic shock syndrome: the great masquerader
  • Google Scholar

More in this TOC Section

  • Lesson of the month 2: A case of coma in a Parkinson's patient: a combination of fatigue, dehydration and high protein diet over the New Year period?
  • Lesson of the month (2): All that glitters is not stroke
Show more Lesson of the month (2)

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians